RMD card
RMD price forecast
ResMed$238,19
P/E now is 21,7. Average over 5 years: 33,4 (range 26–38). The stock is 35% below its history.
Base · FY2031
$545,13+20,3% a year
The base case gives 20,3% a year, above your target of 10%.
Settings
%
No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.
Calculated from your assumptions. Not an investment recommendation.
Base · FY2031$545,13+20,3% a year